AAM Urges CMS To Enforce Its Rightful Power Over Medicare Part D Formularies
As HHS Secretary Nominee RFK Jr. Braces Though Questions During Confirmation Hearings
While the AAM encouraged CMS to impose its “clear authority” to regulate Medicare Part D formularies, the agency announced that the Trump administration will continue the second cycle of Medicare price negotiations, which has been criticized by the US off-patent trade group.
